BSE Live
Oct 17, 16:01Prev. Close
36.50
Open Price
37.23
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Profit & Loss account of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 2.64 | 4.41 | 5.11 | 6.96 | 10.02 | |
Less: Excise/Sevice Tax/Other Levies | 0.06 | 0.00 | 0.00 | 0.32 | 0.16 | |
Revenue From Operations [Net] | 2.58 | 4.41 | 5.11 | 6.63 | 9.86 | |
Total Operating Revenues | 2.58 | 4.41 | 5.11 | 6.63 | 9.86 | |
Other Income | 1.12 | 0.25 | 0.06 | 0.02 | 0.13 | |
Total Revenue | 3.69 | 4.66 | 5.18 | 6.65 | 9.99 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.47 | 2.95 | 3.47 | 4.58 | 7.19 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.05 | 0.07 | 0.00 | |
Operating And Direct Expenses | 0.00 | 0.22 | 0.33 | 0.73 | 0.61 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 0.42 | 0.12 | -0.37 | 0.00 | -0.16 | |
Employee Benefit Expenses | 1.19 | 0.90 | 0.81 | 0.69 | 0.79 | |
Finance Costs | 0.00 | 0.01 | 0.03 | 0.02 | 0.21 | |
Depreciation And Amortisation Expenses | 0.60 | 0.78 | 0.73 | 0.45 | 0.32 | |
Other Expenses | 0.74 | 0.37 | 0.35 | 0.29 | 0.32 | |
Total Expenses | 3.42 | 5.35 | 5.40 | 6.82 | 9.28 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 0.27 | -0.70 | -0.22 | -0.17 | 0.71 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | |
Profit/Loss Before Tax | 0.27 | -0.70 | -0.22 | -0.17 | 0.68 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.14 | 0.07 | 0.00 | 0.08 | 0.00 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | |
Total Tax Expenses | 0.14 | 0.07 | 0.00 | 1.10 | 0.00 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 0.13 | -0.76 | -0.22 | -1.27 | 0.68 | |
Profit/Loss From Continuing Operations | 0.13 | -0.76 | -2.93 | 0.95 | 0.68 | |
Profit/Loss For The Period | 0.13 | -0.76 | -2.93 | 0.95 | 0.68 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 0.84 | -0.64 | -2.48 | 0.81 | 0.58 | |
Diluted EPS (Rs.) | 0.84 | 0.00 | -2.48 | 0.81 | 0.58 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y
07.06.2024
Shukra Pharma Standalone March 2024 Net Sales at Rs 10.88 crore, down 76.47% Y-o-Y